These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 7707384)

  • 21. Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer.
    Raitanen MP; Leppilahti M; Tuhkanen K; Forssel T; Nylund P; Tammela T;
    Ann Chir Gynaecol; 2001; 90(4):261-5. PubMed ID: 11820414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytologic and cystoscopic predictors of recurrence and progression in patients with low-grade urothelial carcinoma.
    Jackson J; Barkan GA; Kapur U; Wojcik EM
    Cancer Cytopathol; 2013 Jul; 121(7):398-402. PubMed ID: 23364860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Replacing cystoscopy by urine markers in the follow-up of patients with low-risk non-muscle-invasive bladder cancer?-An International Bladder Cancer Network project.
    Schmitz-Dräger C; Bonberg N; Pesch B; Todenhöfer T; Sahin S; Behrens T; Brüning T; Schmitz-Dräger BJ
    Urol Oncol; 2016 Oct; 34(10):452-9. PubMed ID: 27381893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of BTA stat Test in follow-up of patients with bladder cancer: results from FinnBladder studies.
    Raitanen MP;
    World J Urol; 2008 Feb; 26(1):45-50. PubMed ID: 18180926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A comparative study of the sensitivity of bladder washing flow cytometry, voided urine cytology and bladder washing cytology in the detection of bladder carcinoma].
    Tachibana M; Jitsukawa S; Tazaki H; Tashiro Y
    Nihon Hinyokika Gakkai Zasshi; 1989 Jul; 80(7):1025-30. PubMed ID: 2607716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concurrent mutations of coding and regulatory sequences of the Ha-ras gene in urinary bladder carcinomas.
    Czerniak B; Cohen GL; Etkind P; Deitch D; Simmons H; Herz F; Koss LG
    Hum Pathol; 1992 Nov; 23(11):1199-204. PubMed ID: 1427748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of the p53 and K-ras gene mutation patterns for cytologic diagnosis of recurrent lung carcinomas.
    Dai Y; Morishita Y; Mase K; Sato N; Akaogi E; Mitsui T; Noguchi M
    Cancer; 2000 Aug; 90(4):258-63. PubMed ID: 10966568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
    Dalbagni G; Han W; Zhang ZF; Cordon-Cardo C; Saigo P; Fair WR; Herr H; Kim N; Moore MA
    Clin Cancer Res; 1997 Sep; 3(9):1593-8. PubMed ID: 9815848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary UBC Rapid and NMP22 Test for Bladder Cancer Surveillance in Comparison to Urinary Cytology: Results from a Prospective Single-Center Study.
    Pichler R; Tulchiner G; Fritz J; Schaefer G; Horninger W; Heidegger I
    Int J Med Sci; 2017; 14(9):811-819. PubMed ID: 28824318
    [No Abstract]   [Full Text] [Related]  

  • 30. The use of urinary nuclear matrix protein 22 (NMP22) as a diagnostic adjunct to urine cytology for monitoring of recurrent bladder cancer--institutional experience and review.
    Önal B; Han Ü; Yilmaz S; Köybasioglu F; Altuğ U
    Diagn Cytopathol; 2015 Apr; 43(4):307-14. PubMed ID: 25488052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidermal growth factor in urine from patients with bladder cancer.
    Saika T; Tsushima T; Nasu Y; Kumon H; Ohmori H
    Urol Res; 2000 Aug; 28(4):230-4. PubMed ID: 11011960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection.
    Park HS; Park WS; Bondaruk J; Tanaka N; Katayama H; Lee S; Spiess PE; Steinberg JR; Wang Z; Katz RL; Dinney C; Elias KJ; Lotan Y; Naeem RC; Baggerly K; Sen S; Grossman HB; Czerniak B
    J Natl Cancer Inst; 2008 Oct; 100(19):1401-11. PubMed ID: 18812553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of semaphorin 3A in patients with urothelial cancer.
    Vadasz Z; Rubinstein J; Bejar J; Sheffer H; Halachmi S
    Urol Oncol; 2018 Apr; 36(4):161.e1-161.e6. PubMed ID: 29288007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of human telomerase reverse transcriptase mRNA in urine of patients with bladder cancer: evaluation of an emerging tumor marker.
    Melissourgos N; Kastrinakis NG; Davilas I; Foukas P; Farmakis A; Lykourinas M
    Urology; 2003 Aug; 62(2):362-7. PubMed ID: 12893365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular screening of multifocal transitional cell carcinoma of the bladder using p53 mutations as biomarkers.
    Xu X; Stower MJ; Reid IN; Garner RC; Burns PA
    Clin Cancer Res; 1996 Oct; 2(10):1795-800. PubMed ID: 9816132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical sensitivity of p53 mutation detection in matched bladder tumor, bladder wash, and voided urine specimens.
    Prescott JL; Montie J; Pugh TW; McHugh T; Veltri RW
    Cancer; 2001 Jun; 91(11):2127-35. PubMed ID: 11391594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microsatellite analysis of urine sediment versus urine cytology for diagnosing transitional cell tumors of the urinary bladder.
    Fornari D; Steven K; Hansen AB; Vibits H; Jepsen JV; Poulsen AL; Schwartz M; Horn T
    APMIS; 2004 Feb; 112(2):148-52. PubMed ID: 15056232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Numerical aberrations of chromosomes 11 and 17 detected by fish--fluorescence in situ hybridization combined with cytology in exfoliated cells from voided urine in patients with urothelial carcinoma of the bladder].
    Asali MG; Kaneti J; Manor E
    Harefuah; 2007 Dec; 146(12):914-9, 1000. PubMed ID: 18254439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Size-based enrichment of exfoliated tumor cells in urine increases the sensitivity for DNA-based detection of bladder cancer.
    Andersson E; Steven K; Guldberg P
    PLoS One; 2014; 9(4):e94023. PubMed ID: 24732047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of urothelial bladder cancer cells in voided urine can be improved by a combination of cytology and standardized microsatellite analysis.
    Wild PJ; Fuchs T; Stoehr R; Zimmermann D; Frigerio S; Padberg B; Steiner I; Zwarthoff EC; Burger M; Denzinger S; Hofstaedter F; Kristiansen G; Hermanns T; Seifert HH; Provenzano M; Sulser T; Roth V; Buhmann JM; Moch H; Hartmann A
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1798-806. PubMed ID: 19454613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.